Computational Identification of Metabolic Pathways of

Plasmodium falciparum using the k-Shortest Path Algorithm by Oyelade, O. J. et al.
Research Article
Computational Identification of Metabolic Pathways of
Plasmodium falciparum using the k-Shortest Path Algorithm
Jelili Oyelade ,1,2 Itunuoluwa Isewon ,1,2 Olufemi Aromolaran,1,2 Efosa Uwoghiren ,1,2
Titilope Dokunmu ,2,3 Solomon Rotimi,2,3 Oluwadurotimi Aworunse,4
Olawole Obembe ,4 and Ezekiel Adebiyi1,2
1Department of Computer & Information Sciences, Covenant University, Ota, Nigeria
2Covenant University Bioinformatics Research Cluster (CUBRe), Ota, Nigeria
3Department of Biochemistry, Covenant University, Ota, Nigeria
4Department of Biological Sciences, Covenant University, Ota, Nigeria
Correspondence should be addressed to Jelili Oyelade; ola.oyelade@covenantuniversity.edu.ng
Received 26 July 2018; Revised 28 November 2018; Accepted 29 July 2019; Published 16 September 2019
Academic Editor: Luigi Ceci
Copyright © 2019 Jelili Oyelade et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Plasmodium falciparum, a malaria pathogen, has shown substantial resistance to treatment coupled with poor response to
some vaccines thereby requiring urgent, holistic, and broad approach to prevent this endemic disease. Understanding the
biology of the malaria parasite has been identified as a vital approach to overcome the threat of malaria. This study is
aimed at identifying essential proteins unique to malaria parasites using a reconstructed iPfa genome-scale metabolic model
(GEM) of the 3D7 strain of Plasmodium falciparum by filling gaps in the model with nineteen (19) metabolites and
twenty-three (23) reactions obtained from the MetaCyc database. Twenty (20) currency metabolites were removed from the
network because they have been identified to produce shortcuts that are biologically infeasible. The resulting modified iPfa
GEM was a model using the k-shortest path algorithm to identify possible alternative metabolic pathways in glycolysis and
pentose phosphate pathways of Plasmodium falciparum. Heuristic function was introduced for the optimal performance of
the algorithm. To validate the prediction, the essentiality of the reactions in the reconstructed network was evaluated using
betweenness centrality measure, which was applied to every reaction within the pathways considered in this study. Thirty-
two (32) essential reactions were predicted among which our method validated fourteen (14) enzymes already predicted in
the literature. The enzymatic proteins that catalyze these essential reactions were checked for homology with the host
genome, and two (2) showed insignificant similarity, making them possible drug targets. In conclusion, the application of
the intelligent search technique to the metabolic network of P. falciparum predicts potential biologically relevant alternative
pathways using graph theory-based approach.
1. Introduction
Malaria remains one of the leading global health challenges
with about 216 million cases and more than 445,000 deaths
recorded in 2016. According to the World Health Organiza-
tion (WHO), 88% of these deaths occurred in Africa [1] and
Plasmodium falciparum accounted for the majority of the
cases. P. falciparum has developed resistance to all antimalar-
ial medications including the most potent one—artemisinin
[2–4]. Some genetic changes and metabolic alterations confer
survival advantage that enables the parasite to evade drug
effects thereby ensuring its survival. However, there is still a
poor understanding of the processes utilized by P. falciparum
to evade drug effects, which also hamper vaccine develop-
ment [5]. The incomplete knowledge of the metabolic path-
ways of P. falciparum has also been identified as a major
impediment towards the development of an effective treat-
ment [6]; hence, the need for intensified research that is
aimed at understanding better the parasite biology. Compu-
tational approach, which predicts metabolic networks and
possible alternative pathways pertinent to the parasite’s sur-
vival, can identify candidate drug targets to eliminate the
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disease globally. Some previous studies have been done in
this regard. Figure 1 explains the various paths (a), pathways
(b), and complete network constructions (c) in metabolic
pathways.
The identification of these undiscovered pathways within
the metabolism of the malaria parasite entails enumerating
not only the shortest path within the metabolic pathway
but also the list of other feasible paths within a source
compound and a target compound. This could be regarded
as an optimization problem. The metabolic system or metab-
olism of a specific cell or an organism is the entire system of
metabolic reactions of the cell or organism. A metabolic
pathway is an associated subsystem of the metabolic system
either as a representation of particular processes or charac-
terized by functional boundaries, e.g., the system between a
glucose (initial substance) and a pyruvate (final substance).
The k-shortest path technique enables the optimal and
suboptimal metabolic pathways to be identified within the
metabolic network [7].
Croes et al. [8] presented a reaction to the representation
of the metabolic network in order to identify relevant path-
ways in a biological network. However, the path finding
algorithm applied was unable to handle a large dataset. Faust
et al. [9] combined a random walk-based reduction of the
graph with the shortest path-based algorithm and applied
on a yeast metabolic network. This approach is computation-
ally intensive due to several runs by the shortest path algo-
rithm used. Oyelade et al. [10] applied a colour coding
algorithm to search for minimum pathways in the P. falci-
parum interaction network. They discovered “identified”
and “unknown” genes and signal transduction pathway
involved in metabolic activities of P. falciparum. However,
this approach is only capable of obtaining the shortest signal
pathway. Also, in another work of Oyelade et al. [11], the
qualitative Petri net model for the glycolysis pathway in P.
falciparumwas built and analysed for its structural and quan-
titative properties using the Petri net theory which only give
insights into the complex net behavior of the pathway. Essen-
tial reactions in the metabolic network of P. falciparum have
been predicted using several computational techniques such
as in silico knockout screening [12], load and choke point
[13], centrality measures [14], flux balance analysis [15],
and machine learning approach [16] etc.
The goal of this study is to computationally identify
branching metabolic pathways of P. falciparum using the
enhanced k-shortest path technique with improved predic-
tion precision. This technique was used in our previous work
[17] although limited to finding only alternative paths in
selected metabolic pathways. In this work, we obtained the
genome-scale metabolic model of the 3D7 strain of P. fal-
ciparum from a previous study [18]. The dataset contains








































Figure 1: (a) describes the paths in a metabolic network construction; (b) describes the pathways; and (c) describes the entire networks of the
metabolic construction.
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architecture of the metabolic network was modelled using
a reaction graph where reactions are designated as the
nodes and two reactions are neighbors, if the product of
a reaction is the substrate of the other. Compound graph
representation is not suitable for path finding algorithms
because a reaction can have more than one compound
as both input and output, e.g., A + B ≥ C +D, thereby lead-
ing to a bunch of redundant edges. The existence of two
different types of nodes in a bipartite graph makes it com-
plex to traverse by the path finding algorithm. The choice
of a reaction graph was informed by the aim of this study,
which is to identify more alternative metabolic pathways,
and the pathways are known to be chains of reactions
and also due to the applicability of path finding algorithms
which requires a single type of node to compute the short-
est paths within the network. The T ∗ algorithm, the k
-shortest path technique developed by Kadivar [19], was
adapted to extract the shortest paths from a defined source
node to a target node. Only two metabolic pathways were
considered for the alternative path analysis in this work due
to the overlapping nature of the pathways that made it diffi-
cult to identify source and target reactions relating to a spe-
cific pathway.
We set the value of k of the path finding algorithm to
equal five (5) because as k increases, the biological relevance
of the path reduces. The identification of essential enzymes in
a particular network allows a possible drug target to be iden-
tified [16, 20–22]. Therefore, in drug development, essential
enzymes are generally recognized as perfect drug target
candidates for potential new drugs and vaccines to treat
and prevent diseases since their deletion from a network
can compromise its integrity [21, 22]. Hence, the essentiality
of reactions was carried out using the betweenness centrality
measure to determine essential reactions within a recon-
structed network and subsequently predicted 32 essential
enzymes.
2. Materials and Methods
2.1. Reconstructing the Metabolic Network. Metabolic reac-
tion data were obtained from Chiappino-Pepe et al.’s study
[18]; also 19 metabolites and 23 reactions were obtained from
the MetaCyc database [23] to fill gaps in the iPfa GEM (see
appendix A for the list of reactions obtained from the Meta-
Cyc database). In a metabolic network, there are several
metabolites that are commonly involved in reactions that
cause shortcuts without biological meaning when computing
paths in a simple graph [24]. These metabolites are referred
to as pool metabolites or currency metabolites such as proton
and water. Most of them often produce biological misinter-
pretations due to the artifactual links between nodes.
Kim et al. [25] identified twenty-five (25) currency
metabolites out of which we eliminated twenty (20) from
the network before reconstructing the graph. The remain-
ing five (5) currency metabolites identified by [16] were left
in the network since their presence does not have a signif-
icant effect that could lead to shortcuts without biological
meaning, and a uniform weight is assigned to all edges in
the network.
2.2. The Algorithm. The T ∗ algorithm was selected among
the other k-shortest paths because of its superior computa-
tional performance (as shown in Table 1). This algorithm
requires topological sorting of the graph nodes as its input,
which is only possible for a directed acyclic graph. Figure 2
shows the algorithm flow chart of the metabolic network
construction.
Given that P i = P1i, P2i,⋯, Pki as the set of the ki
-shortest paths from s to node i and L P1
i ≤ L P2i ≤ L
Pk
i , where L P denotes the length of path P. Let i, j
∈ A, because of topological ordering and since order (j)
is larger than the other nodes in all s – i paths; Pli i, j
is a loopless path for each l ∈ 1, 2,⋯, ki . Therefore if
P s =∅, then P i = j∈A− i PϵP∣j∣ P j, i (stated in
Algorithm 1).
The T ∗ algorithm was modified in two significant ways:
Firstly, we eliminated the first stage (topological order-
ing) due to the nature of the dataset where several reactions
within the dataset could be on the same level in the topolog-
ical order thereby varying the results from each run of the
algorithm. For instance, if reactions A, B, and C have the
same topological order, then it implies that at different runs
of the algorithm, reaction A could come first or reaction B
or reaction C, which varies the result of the algorithm at dif-
ferent runs. The metabolic network of P. falciparum contains
over six hundred compounds and over a thousand reactions.
The inconsistency inherent in the ordering of the reactions
will have severe biological implication for the eventual short-
est paths generated by the algorithm. For instance, if the
order of a vital reaction within the pathway is less than that
of the source compound for a particular pathway, then the
reaction will be omitted from the shortest paths because the
algorithm starts traversing from the source node to the target
node in the topological order. Secondly, the topological
ordering is not applicable to networks with a cycle since met-
abolic networks are known to contain loops; hence, we intro-
duced heuristic function to enhance the prediction precision
of the alternative paths. Figure 3 shows the modified T∗ algo-
rithm for metabolic network construction. The reactions in
the annotated pathway were retrieved and used to guide the
search of the algorithm to list biological feasible paths.
Therefore, the modified T∗ algorithm 2 is given.
Table 1: Time complexity of T ∗, K ∗, Yen, Feng, EA, and LVEA
algorithms. As shown in the Table 1, the T ∗ algorithm has better
computational performance in terms of running time when
compared to others [19].
Algorithm Time complexity
T ∗ O m + nk log d
K ∗ O m + n log n + k
Lazy variant of Eppstein’s
algorithm (LVEA)
O m + n log n + k log k
Eppstein’s algorithm (EA) O m + n log n + k log k
Feng O kn m + n log n
Yen O 1/2 Kn3
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2.2.1. Reward Shaping Formulation. The concept of reward
shaping was also introduced to the k-shortest path algorithm
to improve the quality of biologically relevant alternative
path prediction. Reward shaping is the addition of an extra
reward signal that encodes some heuristic knowledge of the
system designer or domain expert, thus encouraging the
learning agent to explore parts of the state space believed to
contain good solutions [26–28]. In practice, the choice of
reward function is intuitively selected [29] and this has been
successfully applied to speed up reinforcement learning tech-
niques in complex domains [30, 31].
The reward Rk of each feasible path between a source
reaction and target reaction is computed using the number
of reactions within the path that can be found in the set of
annotated reactions RA. An annotated pathway was obtained
from the KEGG database. The justification for this model is
based on the assumption that the annotated pathway for a
metabolic process represents the shortest path; hence, the
next shortest alternative path is most likely to have branched
from the annotated path thereby containing most of the reac-
tions in annotation. The reactions in the feasible path were
compared to the annotated path to determine the number
of intersecting reactions. However, the total cost of a path is
a function of its length and the number of annotated reaction




xic ri , x =
1, if ri ϵ RA,
0, otherwise,
1
whereMk represents the initial reward for path k, c ri repre-
sents the coefficient for reaction (ri) which has a constant
value of 1. xi will assume the value of 1 if ri is present in
the set of annotated reaction for that pathway and 0 if
otherwise.
In addition to the objective, obtaining biologically rele-
vant paths is also to obtain the shortest path; hence, a penalty
function is introduced which is meant to reduce the reward




where t is a “balancing factor”which is an arbitrary value that
is suitable to provide a penalty value that balances the
Perform topological ordering
of network
Next = order (s)
Is MQ(i) = 0
and |P[i]| < k ?
Update the nodes values trav-
ersing up in MQ(i) along the
path of the moved item
Move root item of MQ(i) to
P[j] and replace the moved item




Update (P[next] by P[j], j∊A-
(next))
Next = next + 1
Next <
order (t)
Update (P[i] by P[j], j∊A-(i))
Figure 2: T ∗ algorithm flow chart for metabolic network reconstruction.
1: next = order s ;
2: while next < order(t) do
3: Update(P[next] by P[j], j ∈ A─(next));
4: next = next + 1;
5: end while
6: Update(P[i] by P[j], j ∈ A─ (i))
7: Make min-priority queue MQ(i) by P1 j ∈ P j for j ∈ A─(i)
according to L P1 j + cjivalues.
8: while MQ i ≠∅ and ∣P i ∣ < k do
9: Move P at root of MQ(i) to P[i] and replace the moved item
by its neighbour in the source list from which it came and
update the nodes values traversing up in MQ(i) along the path
of the moved item.
10: end while
Algorithm 1
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positiveness of annotated reactions present in the path and
the disadvantages of the path length.
The reward for a path k is given as the difference between
its initial reward and penalty score as shown in
Rk =Mk − Pk 3
In this study, we chose t to be 0.5 for a fair penalty score
and the adjusted cost is the difference between the number of
reaction in the path and the reward. We then applied the
modified T∗ algorithm to the glycolysis and pentose phos-
phate pathway of P. falciparum to obtain the k-shortest paths
for k = 5.
3. Results
We then applied the modified T∗ algorithm to the glycol-
ysis and pentose phosphate pathway of P. falciparum to
obtain the k-shortest paths for k = 5. Table 2 shows the
number of reactions present in a predicted path and its
computed cost. The five alternative paths identified by
our method for each of the target metabolic pathways
Next = source node
Update next with itself
Update (all adjacent nodes)
Is MQ(i) = 0
and |P[i]| < k ?
Update the nodes values trav-
ersing up in MQ(i) along the
path of the moved item
Move root item of MQ(i) to
P[j] and replace the moved item




Reward paths with known
nodes







Update (P[i] by P[j], j∊A-(i))
Figure 3: Modified T∗ algorithm flow chart for metabolic network reconstruction.
1: next = source;
2: while next = target do
3: Update(P[next] by P[j], j ∈ A─ (next));
4: Compute Rk for P[next]
5: next = next + 1̲;
6: end while
7: Update(P[i] by P[j], j ∈ A─ (i))
8: Make min-priority queue MQ(i) by P1j ∈ P[j] for j ∈ A─ (i)
according to L P1j + cji values.
9: while MQ i ≠∅ and ∣P i ∣ < k do
10: Move P at root of MQ(i) to P[i] and replace the moved
item by its neighbor in the source list from which it came
and update the nodes values traversing up in MQ(i) along
the path of the moved item.
11: end while
Algorithm 2













1 9 8 3.5 5.5
2 10 9 4 6
3 11 9 3.5 7.5
4 11 9 3.5 7.5
5 12 10 4 8
Pentose phosphate
1 8 8 4 4
2 9 9 4.5 4.5
3 10 9 4 6
4 11 11 5.5 5.5
5 11 11 5.5 5.5
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were further verified manually to identify artifacts and bio-
logically plausible paths. Two alternative paths were iden-
tified to be a feasible path for metabolic activities in the
pentose phosphate pathway. One alternative path was
identified in the glycolysis pathway, which could serve as
an alternative path for metabolic activities in the pathway.
The reactions represented in gold in Figures 4 and 5 indi-
cate reactions identified by this study to have created alter-
native paths in the respective metabolic pathways. The
reaction represented in blue in Figure 5 represents a non-
annotated reaction identified by this study to create an
alternative path glucose 6-P to glycolysis.
For the glycolysis pathway, we predicted a pathway,
which could provide an alternative path for the generation
of pyruvate. This metabolic reaction involves alpha-D-glu-
cose-1-phosphate uridylyltransferase. The predicted alterna-
tive paths for the glycolysis pathway are presented in
Figure 4.
The predicted alternative paths for the pentose phosphate
pathway are presented in Figure 5. Two (2) additional meta-
bolic reactions were predicted to have created an alternative
path in the pathway; they are D-glyceraldehyde-3-phosphate
glycolaldehyde transferase and sedoheptulose 7-phosphate 1-
phosphotransferase reactions, respectively.
3.1. Essential Reaction Prediction. To verify the predicted
pathways, a test of the essentiality of these genes was done
on the predicted pathways. Betweenness centrality measure
was applied to the reconstructed metabolic network to each
reaction in the network to determine the essentiality of a par-
ticular metabolic pathway that is critical for the production of
a target compound identified. The betweenness centrality





where bik pj is the proportion of the shortest path linking pi





































Figure 4: Predicted alternative metabolic paths in the glycolysis pathway. The compound (D-glucose-1-P) highlighted in gold represents the
predicted alternative path to the final product (pyruvate).
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path that contain point pj as an intermediary in the shortest
path from pi to pk, and gik is the number of the shortest path





bik pj   i ≠ j ≠ k , 5
where dij is the pair dependency which represents the degree
to which a point, pi, must depend upon another, pj.






where CB pj is the betweenness point centrality.
The genes that coded the enzymes responsible for the
essential reactions discovered were obtained and blasted
against the human genome to evaluate the existence of
homology in the host. We used a centrality score of 0.25 as
the level of significance because the centrality score of some
of our predicted reactions that validated the gold standard
set of essential enzymes and other predicted ones in literature
has a centrality score of approximately 0.3. Table 3 shows the
reactions with a centrality score from 0.25 and above as the
predicted essential reactions. A total of 32 reactions were pre-
dicted as essential, out of which 13 have been validated in the
literature.
3.2. Visualization of Predicted Pathway. Figures 6(a) and 6(b)
are the visualization of the predicted glycolysis pathway
where Figure 6(a) represents the unevaluated version of the
particular pathway while Figure 6(b) represents the pathways
of the betweenness centrality measure. The nodes with the
biggest structure in Figure 6(b) represent the predicted essen-
tial reactions of the pathway. Similarly, Figures 7(a) and 7(b)
are the visualization of the predicted glycolysis pathway


































Figure 5: Predicted alternative metabolic paths in the pentose phosphate pathway. The compounds (D-xylulose-5P and glycerone
phosphate) highlighted in gold represent the predicted alternative paths to the final product. The compound (sedoheptulose 1,7
biphosphate) highlighted in blue is the predicted nonannotated compound in the pathway.
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particular pathway while Figure 7(b) represents the pathways
that the betweenness centrality measure has been applied.
The biggest nodes in Figure 7(b) denote the predicted essen-
tial reactions of the pathway.
4. Discussion
Several P. falciparum metabolic network reconstructions
have been done previously, but this study is aimed at predict-
ing alternative metabolic pathways for energy generation in
the malaria parasite via the pentose phosphate and glycolytic
reactions using the k-shortest path algorithm. The essential-
ity of these reactions to the survival of these parasites was also
evaluated in the predicted models (Table 3) and genes with
no human homologs identified (Table 4). Sequence align-
ment was performed for all the 32 enzymes to identify the
existence of homology; two of the enzymes show insignifi-
cant similarity with the host. Energy production in apicom-
plexans involves both the aerobic and anaerobic pathways,
and this varies from species to species [32]. P. falciparum is
a fast growing organism in the human erythrocyte. There-
fore, in order to meet its energy need for growth and cell divi-
sion, it relies on anaerobic oxidation of glucose to generate
ATP. This is achieved through a series of enzyme-catalyzed
breakdown of glucose to pyruvate, a metabolic process other-
wise called the glycolysis or Embden–Meyerhof–Parnas
pathway [33]. This process does not require oxygen to gener-
ate ATP, but results in the accumulation of pyruvate. While
the main purpose of glycolysis is to generate ATP, one of
its intermediates, glucose-6-phosphate, is the precursor for
the pentose phosphate pathway [34]. This pathway serves
an important purpose of generating NADPH and pentose
(a) (b)
Figure 6: (a) Predicted glycolysis pathway. (b) Predicted essential glycolysis pathway.
(a) (b)
Figure 7: (a) Predicted pentose phosphate pathway. (b) Predicted essential pentose phosphate pathway.
Table 4: Predicted essential genes with no homologs in the human genome.
Gene name Enzyme name E.C. number Biological process
PF3D7_1343000 Phosphoethanolamine N-methyltransferase 2.1.1.103 Glycerophospholipid
PF3D7_1437200 Ribonucleoside-diphosphate reductase 1.17.4.1 Purine/pyrimidine
10 International Journal of Genomics
sugars, which are moieties needed for the synthesis of nucleic
acids and membrane lipids that are molecular raw materials
needed by the parasite for cell division.
Similarly, different stages of malaria parasites have
been reported to have different energy requirements while
P. falciparum-resistant strains have been shown to alter
their genetic and metabolic pathways, in order to utilize
nutrient requirements for fitness and survival in a drug
environment. A recent study identified metabolic changes
in mutant parasites, which shows differential transport and
utilization of nutrients, as shown in computational predic-
tion that incorporates metabolomics data from sensitive
and resistant isolates [35]. Malaria parasite also lacks capabil-
ity to store carbohydrates [36, 37]; it constantly requires the
production of this through glucose and can utilize other
carbohydrate precursors scavenged from a host such as
UDP-glucose; hence, the identified alternative metabolic
pathways that P. Falciparum utilizes for survival are crucial
for curbing drug resistance and can be targeted as vaccine
candidates to reduce malaria transmission. Variable regula-
tion of host UTP-glucose-1-phosphate uridylyltransferase
(UDP-glucose phosphorylase), which catalyzes energy-
generating reactions such as galactose metabolism and glyco-
gen synthesis, has been reported [34] thereby making it a
good target. This was identified as an essential pathway in
glycolysis in the present study. Other predictions from this
study corroborate the findings from other studies; these are
highlighted in Table 3. Amino acid deprivation can alter
the growth of P. falciparum in vitro; however, it may not
completely kill the parasite [38]. This regulation of nutrient
requirement to cope with deficit is one of the many survival
mechanisms already identified in the parasite. However,
other essential amino acid pathways identified can be tar-
geted together to achieve a detrimental effect on the parasite’s
survival. Our study identified gamma-L-glutamyl-L-cystei-
ne:glycine ligase as an essential reaction for glycine, serine,
and threonine metabolism. This finding has been previously
reported in other studies [18, 39].
For the cysteine and methionine pathways, hemoglobin
digestion is essential for the malaria parasite; L-methionine
transport reaction and L-cysteine:2-oxoglutarate amino-
transferase were also predicted as essential reactions. The
altered transport of nutrients across the membrane may also
vary in sensitive and resistant parasites [35]; hence, vaccines
or therapies that target these pathways will provide poten-
tially lethal effects on the parasites. Other predicted essential
reactions within the glycerophospholipid pathway are 1,2-dia-
cyl-sn-glycerol transport reaction, L-methionine s-adenosyl-
transferase, and s-adenosyl-L-methionine (only the latter has
validated predictions in the literature [40–42]). In the glyco-
lytic pathway, three reactions: D-glyceraldehyde-3-phosphate;
D-fructose-1,6-bisphosphate D-glyceraldehyde-3-phosphate-
lyase; and UTP:D-fructose-6-phosphate 1-phosphotransfer-
ase, were predicted as essential reactions with D-glyceralde-
hyde-3-phosphate-lyase validated in the literature [43]. Five
reactions, namely, inositol-1,4-bisphosphate 1-phosphatase;
phosphatidylinositol-3,4-bisphosphate 4-phosphatase; 1-D-
myoinositol-3-phosphate phosphohydrolase; CDP-diacylgly-
cerol:myo-inositol 3-phosphatidyltransferase; and inositol-
1,3,4-trisphosphate 5/6-kinase, were the predicted essential
reactions within the inositol phosphate pathway out of which
CDP-diacylglycerol:myo-inositol 3-phosphatidyltransferase is
validated [18, 44]. It is noteworthy that D-glyceraldehyde-3-
phosphate dehydrogenase has homolog in the human genome
(Table 4).
Similarly, our study predicted a metabolite—sedohep-
tulose-1,7-diphosphate—from the breakdown of xylulose,
in the pentose phosphate pathway, which may be utilized
by the parasite to scavenge for energy. Only sedoheptu-
lose-7-phosphate:D-glyceraldehyde-3-phosphate glycolalde-
hyde transferase was predicted as an essential reaction
within the pentose phosphate pathway. P. falciparum
essentially synthesize nucleotides de novo. Hence, it cannot
salvage pyrimidines from an extracellular environment.
This biosynthetic pathway has been identified as a good
target for malaria control [45]. For the purine and pyrim-
idine pathways, five and four reactions were predicted as
essential and have been reported in other studies (see
details in Table 3). The implications of these hypothesis
are that in addition to other predicted pathways, if biolog-
ically validated through disruption of genes, encoding the
enzymes for these pathways in P. falciparum will further
elucidate survival and alternate energy generation path-
ways in the parasite. The hypothesized potential pharma-
cological enzyme targets essential for the parasite can be
targeted to control malaria infection globally.
5. Conclusions
In this work, we have been able to predict alternative meta-
bolic paths in the glycolysis and pentose phosphate pathways
of P. falciparum. We predicted two (2) essential proteins in
the glycerophospholipid, purine, pyrimidine, and glycolysis
metabolic pathways (Table 4) without homology with a host.
With the use of heuristic function to enhance the k-shortest
path algorithm, we have been able to identify potential bio-
logically relevant paths using a computational graph-based
technique which hitherto is less utilized due to its very high
false positive result. Biologically targeting these candidate
proteins in Plasmodium is recommended to improve under-
standing of the predicted alternative pathways and the preci-
sion of the graph theory-based method.
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